Blockchain Registration Transaction Record
Calidi Biotherapeutics Advances in Targeted Cancer Therapies Amid Financial Improvements
Calidi Biotherapeutics reports Q2 2025 results, showcasing progress in cancer therapy development and financial improvements. A beacon of hope for metastatic disease treatment.

This news is crucial for investors and the medical community as it highlights Calidi Biotherapeutics' progress in developing potentially life-saving cancer therapies. The reduction in net loss and the advancement in clinical trials underscore the company's growing stability and innovation in the biotechnology sector. For patients with metastatic diseases, Calidi's developments offer new hope for effective treatments, marking a significant step forward in the fight against cancer.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0xc857a9af99709dfa7d17a8c7ff4c5adc59af69e19a3b14ca60634028bdce9d26 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | yawn6_uv-702c6fd9aa37c49867121a3ec971e15e |